Introduction
When quiescent cells are stimulated to enter the cell cycle they undergo a transition state before they enter the G1 phase. This G 0 /G 1 transition is characterized by the transient and precisely timed activation of a number of genes. The ®rst genes to be induced are the immediate early genes. They are induced by preformed transcription factors which are activated in response to the proliferation promoting signal. Consequently, the transcriptional stimulation of immediate early genes is independent of protein synthesis. Several of these immediate early genes encode transcription factors which become engaged in the activation of delayed early genes (Herschman, 1991; Lau and Nathans, 1991) . The proteins of the Fos and Jun families are among the best studied immediate early transcription factors and of relevance to this study. The four members of the Fos family (c-Fos, FosB, Fra-1, and Fra-2) can heterodimerize with the three members of the Jun family (c-Jun, JunB, and JunD) to form a large array of dierent AP-1 complexes (Angel and Angel and Herrlich, 1994) .
The stimulation of quiescent cells with growth factors triggers the signal transduction cascade which includes the Ras and Raf oncoproteins, MEK and the two MAP kinases ERK-1 and ERK-2. Upon activation, the latter translocate into the nucleus where they catalyze the phosphorylation of several proteins including the ternary complex factor Elk-1. This transcription factor binds in conjunction with serum response factor (SRF) to the serum response element in the promoters of some immediate early genes such as the c-fos gene and thereby triggers their transcriptional activation (Karin, 1994; Marshall, 1995; Seger and Krebs, 1995; Treisman, 1992) . Oncogenic Ras is altered in such a way that it no longer needs an input signal in order to stimulate the ERK signal transduction cascade. Consequently, the expression of oncogenic Ras should result in the permanent activation of the cfos gene unless inhibitory signals come into play which turns the signal o. Elevated AP-1 activity has been found in ras transformed cells and taken as evidence for the constitutive activation of the c-fos gene. Likewise, the experimental induction of ras oncogene expression was shown to lead to c-fos gene activation (Bar and Feramisco, 1986; Feramisco et al., 1985; Gutman et al., 1991; Schonthal et al., 1988; Stacey et al., 1987) . In contrast, there are reports which describe the silencing of the c-fos and other immediate early genes in oncogenically transformed cells Suzuki et al., 1989; Yu et al., 1993; Zullo and Faller, 1988) .
Previously, in a search for genes that are activated in response to the induced expression of a Ha-ras oncogene, we have isolated among others, cDNA clones derived from the T1 gene Werenskiold et al., 1989) . T1 is a delayed early gene which is transiently activated in response to the stimulation of quiescent cells with serum, lysophosphatidic acid (LPA), the growth factors PDGF, aFGF, and bFGF, by TPA, and the proin¯ammatory cytokines TNFa and IL-1 (Kumar et al., 1997; Laursen et al., 1998; Werenskiold et al., 1989; and unpublished results) . Its expression could also be induced through the conditional activation of a c-Fos-estrogen receptor hybrid protein ). An enhancer has been identi®ed 3.6 kb upstream of the transcription initiation site, which contains three essential E-boxes and a TRE, the binding sites of helix-loop-helix transcription factors and AP-1, respectively (Kessler et al., 1997; .
In ®broblasts, the T1 gene is transcribed into a 2.7 kb mRNA which encodes a secreted protein with signi®cant similarity to the extracellular domain of the interleukin-1 receptors Tominaga, 1989 ). In proliferating ®broblasts there is very little T1 mRNA and its level is even more decreased upon entry of the cells into the quiescent state. Reentry of these cells into the cell cycle is followed by a dramatic transient accumulation of T1 mRNA which reaches its maximal level after 6 h and rapidly disappears thereafter . In mast cells the T1 gene is transcribed from a dierent promoter which lies 10.5 kb proximal to the one used in ®broblasts (GaÈ chter et al., 1996) . Mast cell speci®c T1 gene expression is regulated by GATA transcription factors but not AP-1. A 5 kb T1 mRNA accumulates which encodes a protein resembling the type I IL-1 receptor. Its ectodomain is identical with the T1 protein produced in ®broblasts (Yanagisawa et al., 1992) . Using a recently generated T1 speci®c monoclonal antibody (Moritz et al., 1998b) we could detect the membrane anchored form of T1 exclusively in mast cells (Moritz et al., 1998a) .
While we originally found strong T1 gene induction following the conditional expression of the Ha-ras (EJ) and v-mos oncogenes we later observed and report here that under conditions of sustained oncogene expression the T1 gene is no longer transcribed and even rendered unresponsive to growth factor and serum mediated stimulation. We report here that the sustained Ha-ras oncogene expression in NIH3T3 cells leads to the accumulation of Fra-1 and postulate that the high level of AP-1, consisting mainly of Fra-1/c-Jun heterodimers in ras transformed ®broblasts results in the silencing of the c-fos gene. The lack of c-fos gene expression in ras transformed cells is the likely cause for attenuated T1 gene expression. We conclude that the downregulation of c-fos in ras transformed NIH3T3 cells results in the loss of basal T1 gene transcription and unresponsiveness of the T1 gene to mitogenic stimulation.
Results
Induced but not sustained expression of the Ha-ras oncogene results in T1 gene expression Previously, we have demonstrated that the induction of Ha-ras oncogene expression resulted in the activation of the T1 gene. In these experiments we have used a cell line which contains a Ha-ras oncogene under the control of the glucocorticoid hormone inducible promoter of the mouse mammary tumor virus (MMTV) (Jaggi et al., 1986) . Peak levels of T1 mRNA are reached around 8 h following hormone addition. However, prolonged hormone treatment resulted in the downregulation of T1 gene expression . Earlier, it has been observed by several investigators that ligand activated glucocorticoid receptor can interact with AP-1, and that this interaction mutually attenuates the transcriptional transactivation potential of both transcription factors (Diamond et al., 1990; Kerppola et al., 1993) . Such a mechanism could be the cause for the transient nature of T1 mRNA accumulation since AP-1 is involved in ras mediated T1 gene induction. Alternatively, the downregulation of the T1 gene could be due to prolonged Ha-ras oncogene expression. To distinguish between these two possibilities we have produced the NIH3T3 derived cell line TAR, containing a Ha-ras (EJ) oncogene construct which is regulated by a bestradiol-activatable transactivator (Scheier et al., manuscript in preparation). Since NIH3T3 cells are devoid of estrogen receptors, b-estradiol treatment does not in¯uence endogenous gene expression or cellular metabolism. b-estradiol stimulation of TAR cells resulted in the rapid synthesis of Ha-ras mRNA ( Figure 1a ) and their morphological transformation within 2 days. Ha-ras oncogene expression initially resulted in the accumulation of T1 mRNA. However, upon prolonged b-estradiol treatment T1 mRNA levels . RNA was collected and 5 mg of total RNA was subjected to Northern blot analysis. The Northern blot was hybridized in succession with T1 and ras speci®c DNA probes without stripping the hybridized probe in between. (b) Ha-ras transformed NFR-2 and parental NIH3T3 cells were either growth arrested in 0.5% FCS for 24 h or left untreated (g, exponentially growing). Starved cells were serum stimulated with DMEM containing 10% FCS for the indicated time periods (h). The same Northern blots were hybridized with a T1 probe followed by a proliferin probe dropped despite sustained expression of the Ha-ras oncogene ( Figure 1a) . Thus, the transient nature of T1 gene expression in response to ras oncogene induction is a consequence of biochemical changes triggered by the Ras oncoprotein and not an artifact of the conditional expression system. The T1 gene is also induced in response to the stimulation of quiescent cells with serum . However, in the NIH3T3 derived cell line NFR-2, which constitutively expresses the Ha-ras oncogene, serum mediated T1 gene expression is abrogated. In contrast, proliferin, which is also an AP-1 responsive gene, is permanently expressed in NFR-2 cells and superinduced in response to mitogenic stimulation with serum ( Figure 1b) . The same phenomenon was observed with TAR cells which were treated for several days with b-estradiol (data not shown).
Many transformed cell lines secrete growth factors which act in an autocrine fashion to support proliferation even in the absence of exogenously supplied mitogens. Consequently these cells cannot be rendered quiescent by serum deprivation, and serum addition does not induce a G 0 /G 1 transition. We investigated whether the inability to induce cell cycle arrest upon serum starvation was the cause for the lack of T1 gene expression in NFR-2 cells. The serum concentration in the medium was reduced from 10 to 0.5% and cell numbers were determined during the following 4 days. We observed that serum starvation induced complete cell cycle arrest in NIH3T3 and NFR-2 cells alike and that the subsequent serum stimulation resulted in the same rapid onset of proliferation in both cell lines (Figure 2a) . Moreover, we demonstrated that the extent of cell cycle entry, as measured by the number of cells in the S-phase, was proportional to the serum concentration over the range of 0.5 ± 6% and that this concentration dependency is indistinguishable for NIH3T3 and NFR-2 cells ( Figure  2b ). Thus the lack of T1 gene expression in NFR-2 cells cannot be explained by the inability of these cells to arrest proliferation upon serum starvation.
NFR-2 cells constitutively express elevated AP-1 binding activity
We have previously shown that the T1 gene contains an essential AP-1 binding site (TRE) within its enhancer sequence (Kessler et al., 1997; and that experimentally induced expression of the c-fos or the fosB genes is sucient for T1 gene activation . Constitutively elevated AP-1 activity and enhanced expression of several AP-1 responsive genes such as those encoding stromelysin, interstitial collagenase, proliferin, and VEGF is a widespread phenomenon among several transformed cell lines and tumors. Based on these observations one would expect elevated AP-1 activity in the ras transformed NFR-2 cells and consequently increased rather than attenuated T1 gene expression. We performed electrophoretic mobility shift assays (EMSA) with nuclear extracts derived from serum deprived and from serum stimulated NIH3T3 and NFR-2 cells and an oligonucleotide with the TRE sequence of the T1 gene enhancer. While the AP-1 binding activity was low in non cycling NIH3T3 cells and transiently increased after serum stimulation, it was permanently high in NFR-2 cells irrespective of the proliferative state of these cells (Figure 3a, b ). To directly demonstrate that the observed DNA-protein complexes consisted of Fos and Jun proteins, we performed antibody interference experiments. The addition of polyclonal antisera speci®cally recognizing either Fos or Jun family member proteins prevented the formation of the DNA-protein complexes with nuclear extracts from both cell lines (Figure 3c ). This Altered expression of the fos and jun family members in Ha-ras transformed cells AP-1 complexes are composed of proteins belonging to the Jun and Fos family which consist of three and four members, respectively. Thus, many dierent AP-1 complexes can form depending on the expression of the various fos and jun genes. The presence of dierent AP-1 complexes in serum stimulated NIH3T3 cells and in ras transformed NFR-2 cells could explain our paradox observation that the AP-1 responsive T1 gene is downregulated in ras transformed cells despite increased AP-1 activity. To evaluate this possibility we analysed the expression pattern of all jun and fos genes in serum starved and serum stimulated NIH3T3 and NFR-2 cells (Figure 4a ). The most striking observation is the complete lack of c-fos mRNA in starved and serum stimulated NFR-2 cells (Figure 4a ). The expression of three other genes, fosB, fra-2, and junB was strongly reduced in NFR-2 cells. In contrast, fra-1 mRNA was present in these cells at all times while it accumulated only transiently in NIH3T3 ®broblasts during the entry of serum starved cells into the cell cycle (Figure 4a and b) . To demonstrate that the accumulation of fra-1 mRNA in NFR-2 cells under normal growth conditions is indeed a consequence of ras oncogene expression we performed experiments with two cell lines harboring an inducible ras oncogene ( Figure 4c ). Induction of the ras oncogene by treatment of TAR cells with b-estradiol resulted in the slow accumulation of fra-1 mRNA which remained abundant as long as b-estradiol treatment was continued. The HLE cell line is a derivative of NIH3T3 cells carrying the Ha-ras (EJ) oncogene under the control of the glucocorticoid inducible promoter of mouse mammary tumor virus (MMTV) (Jaggi et al., 1986) . Treatment of these cells with the synthetic glucocorticoid hormone dexamethasone (Dex) resulted in the accumulation of fra-1 mRNA. Hormone withdrawal is followed by the disappearance of fra-1 mRNA. The treatment of the parental NIH3T3 cells with b-estradiol and Dex did not stimulate fra-1 mRNA accumulation (data not shown).
The mRNA of the two jun family members c-jun and junD were expressed at similar levels in NIH3T3 and NFR-2 cells.
Based on these results we expected to ®nd in NFR-2 cells AP-1 complexes that are mainly composed of Fra-1 and c-Jun or JunD. EMSA experiments were performed with nuclear extracts from serum stimulated NIH3T3 and NFR-2 cells and the TRE element from the T1 enhancer. An antibody against c-Fos partly interfered with DNA binding of AP-1 in protein extracts derived from NIH3T3 but not from NFR-2 cells. In contrast, anti-Fra-1 antibodies substantially reduced AP-1-TRE complex formation in extracts from NIH3T3 and NFR-2 cells (Figure 4d ). These results are consistent with our gene expression data ( Figure 4A ). Fra-1 predominates in the AP-1 complexes derived from NFR-2 cells while both, c-Fos and Fra-1 are found in AP-1 complexes in serum stimulated NIH3T3 cells.
Antibodies directed against c-Jun and JunD interfered with DNA binding of NFR-2 derived AP-1 complexes. Thus, both proteins appear to participate in complex formation with the TRE in the T1 gene enhancer.
These results indicate that the predominant form of AP-1 in NFR-2 cells which can bind in vitro to the T1 TRE consist of Fra-1 and c-Jun/JunD.
A T1 promoter construct does not respond to enhanced AP-1 activity in NFR-2 cells Elevated AP-1 activity in ras transformed cells is thought to be the cause for the enhanced expression of several AP-1 responsive genes. We assume that the AP- Figure 3a was performed three times and the results quanti®ed by densitometric scanning of the autoradiograms, standard deviations are given by the error bars. The highest value (3 h serum stimulation) was taken as 100%. (c) Proteins in nuclear extracts from NIH3T3 and NFR-2 cells, which were serum stimulated for 3 h, were allowed to form complexes with the labeled T1-TRE for 10 min. Antibodies that recognize all family members of Fos and Jun proteins were added as indicated. After incubation for 30 min the samples were subjected to gel electrophoresis Figure 4 Gene expression of fos and jun family members in NIH3T3 and NFR-2 cells after serum stimulation. (a) Serum starved NIH3T3 and NFR-2 cells were stimulated with 10% FCS for 30 min, 1, 2 or 4 h. RNA was collected and subjected to Northern blot analysis. Seven identical Northern blots were prepared and hybridized with the probes indicated. Representative ethidium bromide stained gels are depicted below the autoradiograms. (b) Serum starved NIH3T3 and NFR-2 cells were stimulated with 10% FCS for the indicated times in hours. 5 mg of total RNA were subjected to Northern blot analysis using a fra-1 speci®c DNA probe. g, growing. (c) TAR cells, carrying the b-estradiol inducible Ha-ras oncogene were treated with b-estradiol for 0, 2, 4, 6 h, 1 and 7 days. HLE cells which harbor an MMTV-LTR driven Ha-ras oncogene were left untreated or were treated with 1 mM dexamethasone (Dex) for 24 h. RNA was collected and analysed on a Northern blot for fra-1 mRNA accumulation. (d) EMSA experiments were performed with nuclear extracts derived from NFR-2 and NIH3T3 cells which were serum stimulated for 3 h. Following incubation of nuclear extracts with the T1-TRE probe for 10 min antibodies were added that recognize speci®c family members of Fos and Jun proteins as indicated. The samples were subjected to gel electrophoresis after a further incubation for 30 min. The degree of inhibition of AP-1 DNA binding activity was determined by phosphoimager scanning of the intensity of the residual complex after addition of indicated antibody to the binding reaction. The indicated values are the means of three experiments using independently prepared nuclear extracts and standard deviations are given by the error bars. The values obtained without the inclusion of an antibody were taken as 100% 1 complex, which predominates in these cells, can activate some AP-1 responsive genes but not others, including T1. To test this hypothesis we introduced CAT reporter gene constructs driven by two dierent AP-1 responsive promoters into NIH3T3 and NFR-2 cells. A reporter gene containing a minimal promoter and ®ve TREs from the interstitial collagenase gene was approximately 16-fold more active in NFR-2 than in NIH3T3 cells ( Figure 5 ). This most likely re¯ects elevated AP-1 activity in NFR-2 cells and indicates that these TREs in the context of this reporter construct are recognized by the AP-1 complexes in NFR-2 cells. In contrast, a reporter gene under the control of the T1 promoter, including the enhancer element, is less actively expressed in NFR-2 cell than in NIH3T3 cells despite strongly enhanced AP-1 activity in the former cell line. We take this ®nding as an indication that the T1 gene is not activated by the Fra-1/c-Jun complexes, which predominate in NFR-2 cells.
Ectopic expression of c-fos in ras transformed ®broblasts renders T1 serum inducible
We have previously demonstrated that the T1 gene responds strongly to c-Fos. Here we have shown that the c-fos gene is not expressed in NFR-2 cells. We assume that the absence of c-Fos is the reason why there is no T1 gene expression in ras transformed cells. To test this hypothesis we generated cell lines which express the activated Ha-ras oncogene and synthesize an activatable c-Fos protein. This protein consists of cFos and the ligand binding domain of the estrogen receptor. In the absence of b-estradiol the c-Fosestrogen receptor hybrid protein (c-Fos hER) is inactive but becomes active upon hormone binding. A NIH3T3 cell line, which constitutively express the cFos hER transgene (Schuermann et al., 1993) , was transfected with the Ha-ras (EJ) oncogene and T1 gene expression was analysed in ®ve transformed clones which express the Ha-ras oncogene as revealed by Northern blot analysis (Figure 6b ). There was no T1 gene expression in response to serum stimulation in all of them, consistent with the results obtained with NFR-2 cells (Figure 6a) . However, treatment of these cell lines with b-estradiol led to the accumulation of similar amounts of T1 mRNA as in serum stimulated NIH3T3 cells or in the parental NIH/c-Fos hER cells (Figure 6a) . We conclude that the absence of T1 gene expression in ras transformed ®broblasts is due to attenuated c-fos gene expression and not due to an inhibitory component which blocks the T1 gene and which accumulates in these cells. Figure 5 T1 promoter reporter gene expression in NIH3T3 and NFR-2 cells. NIH3T3 and NFR-2 cells were transiently transfected with promoter reporter gene constructs and pRSVLacZ. SH4.9 contains 4.9 kb of the T1 promoter including the enhancer at the position 73.6 kb, the ®rst exon and intron as well as part of the second exon up to but excluding the ATG initiation codon. 56TRE contains an arti®cial promoter consisting of ®ve concatamerized copies of the collagenase gene TRE in front of the thymidin kinase minimal promoter in the plasmid pBLCAT2. Protein extracts were prepared 48 h after transfection and CAT assays were performed with lysates normalized for b-galactosidase activity. The values are the average of three independent experiments and the standard deviations are given by the error bars Having shown that blocked c-fos gene expression in ras transformed ®broblasts is the cause for the absence of serum mediated T1 gene induction we asked why the cfos gene is silent in these cells. It has been shown earlier that the c-fos gene is repressed by AP-1 (Lin et al., 1988; Mechta et al., 1997; Nose et al., 1989; Okimoto et al., 1996; Suzuki et al., 1989; Zullo & Faller, 1988) . Thus, the likely cause for c-fos gene repression in NFR-2 cells is the elevated AP-1 activity in these cells. Since the predominant form of AP-1 consists of Fra-1 and c-Jun we were particularly interested in analysing whether forced overexpression of these genes leads to c-fos gene repression. A c-fos promoter CAT reporter construct (FosWtCAT) (OseiFrimpong et al., 1994) was transiently transfected in the presence or absence of expression plasmids encoding fos and jun members into NIH3T3 cells. As expected, expression of Fra-1 and c-Jun led to signi®cant c-fos promoter repression (Figure 7 ). If combined, these two proteins caused very strong suppression. Transfection of an expression plasmid encoding JunD activated the c-fos promoter. However, in combination with Fra-1, JunD had a slightly repressive eect. Expression of c-fos, fosB, fra-2 or junB, which are either poorly or not expressed in NFR-2 cells (Figure 4) , had no or a less pronounced inhibitory eect on c-fos promoter activity. This experiment demonstrates that the AP-1 complexes, which are abundant in NFR-2 cells (c-Jun/Fra-1 and possibly c-Jun homodimers), have a strong potential to suppress c-fos promoter activity.
Expression of dominant negative c-Jun releases c-fos promoter suppression in ras transformed cells
To unambiguously demonstrate that the elevated AP-1 activity in NFR-2 cells is the cause for c-fos gene repression, we introduced a dominant negative mutant form of c-Jun (D9Jun) into NFR-2 cells and investigated its eect on c-fos promoter activity. D9Jun has been shown to act as an inhibitor of AP-1 activity (Lloyd et al., 1991) . Expression of mutant cJun in NFR-2 cells increases c-fos promoter activity in a dose dependent manner, probably by heterodimerizing with Fra-1 and thereby titrating out active AP-1 (Figure 8a ). This result indicates that AP-1 activity is indeed a repressor of the c-fos promoter in NFR-2 cells.
To investigate whether our ®ndings in NFR-2 cells also apply to other systems, we used Ki-ras transformed NIH3T3 cells (DT) and a morphologic revertant (DTR1) thereof, which emerged following the stable introduction of D9Jun (Lloyd et al., 1991) . DT cells behaved like NFR-2 cells in that they did not induce the c-fos gene in response to serum stimulation (Figure 8b ). In contrast, the revertant cell line DTR1 exhibited restored c-fos inducibility.
We conclude from these results, that AP-1 activity is involved in c-fos gene repression in ras transformed cells.
Discussion
This study was performed to investigate the reason for the lack of T1 gene induction in ras transformed ®broblasts. T1 was originally identi®ed as a gene which is strongly induced during the onset of Ha-ras and vmos oncogene expression. Promoter analyses have revealed the presence of an essential TRE in the enhancer element and the ectopic expression of c-fos and fosB was sucient to induce T1 gene expression eciently . Therefore, it came as a surprise to ®nd that the T1 gene was inactive in ras transformed cells that contain highly elevated levels of AP-1 activity. An explanation was oered by the ®nding that the composition of the AP-1 complexes diered in normal and in ras transformed ®broblasts. Expression of c-fos and fosB was strongly reduced in mitogen stimulated ras transformed cells while fra-1 expression was high and constitutive. A similar ®nding was recently reported by Mechta et al., (1997) . We could show that the forced expression of c-fos was sucient to reactivate the T1 gene in ras transformed cells, indicating that attenuated c-fos expression rather than the accumulation of an inhibitor, which blocks the T1 gene, is the cause for T1 gene repression. These results indicate that only a subset of AP-1 complexes can induce the T1 gene. We assume that AP-1, consisting of c-Fos and c-Jun that predominates at early times of mitogenic stimulation of quiescent ®broblasts and shortly after the onset of oncogene Figure 7 Response of a c-fos promoter reporter construct to the expression of fos and jun family members in NIH3T3 cells. NIH3T3 cells were transiently transfected with the c-fos promoter CAT reporter construct fosWtCAT and pRSV-LacZ in the absence or presence of expression plasmids encoding dierent fos and jun family members as indicated below the bars. Protein extracts were prepared 24 h after transfection. CAT activity was determined with lysates normalized for b-galactosidase activity. The values are the average of three independent experiments and the error bars give the standard deviations. The value obtained in the absence of cotransfected expression constructs was taken as 100% expression triggers T1 gene activation. In contrast, Fra-1 containing AP-1 complexes, which predominate in ras transformed cells, cannot activate the T1 gene. The repression of T1 gene activity, presumably as a consequence of fra-1 overexpression, is reminiscent of the downregulation of human papillomavirus type 16 transcription in response to antioxidant treatment. Human keratinocytes respond to antioxidants by an increase of AP-1 consisting primarily of Fra-1/JunB which represses rather than activates the AP-1 dependent viral genes (Rosl et al., 1997) . Other AP-1 responsive genes behave dierently. The proliferin gene was shown to be activated by Fra-1 (Groskopf and Linzer, 1994) and we assume that it is the high amount of Fra-1 in NFR-2 cells which accounts for the elevated level of proliferin mRNA that we observed in these cells. Proliferin is an angiogenic factor and might be involved in the neovascularization of tumors. Other AP-1 responsive genes encoding proteins involved in tumorigenesis such as the proteases stromelysin and interstitial collagenase as well the angiogenic growth factor VEGF are constitutively expressed at high levels in many transformed cell lines and in tumors where their activation might be controlled by elevated levels of Fra-1 containing AP-1 (Battista et al., 1998; Vallone et al., 1997) .
How the fra-1 gene is activated in ras transformed cells remains to be investigated. It was reported that cFos stimulates fra-1 gene expression (Bergers et al., 1995; Braselmann et al., 1992 Braselmann et al., , 1993 Brusselbach et al., 1995; Miao and Curran, 1994; Schuermann et al., 1993) . While this might be the mechanism operating in mitogenically stimulated normal ®broblasts it is unlikely to account for the permanent fra-1 gene activity in ras transformed cells since these cells do not express c-fos. Ras communicates with several signal transduction cascades. In addition to the stimulation of the Raf-MEK-ERK pathway it also causes the permanent activation of the JNK pathway resulting in constitutively phosphorylated, active c-Jun Hibi et al., 1993; Smeal et al., 1991) . Since fra-1 gene expression was reported to be stimulated by AP-1 (Bergers et al., 1995) , the AP-1 complexes, which predominate in ras transformed cells, possibly maintain fra-1 gene expression. In neoplastically transformed thyroid cells fra-1 has been described as one of the target genes of the high mobility group I C (HMGI-C) protein which is upregulated in these cells and which is essential for the transformed phenotype (Vallone et al., 1997) .
Recently evidence has been provided that Fra-1 is involved in the establishment of the transformed phenotype. Vallone and coworkers (1997) have observed that the fra-1 gene is induced in neoplastically transformed rat thyroid cells and that interference with its expression leads to a partial reversion of the transformed phenotype. However, overexpression of fra-1 alone was not sucient to trigger cell transformation. Likewise, Mechta et al., (1997) have found that ectopic expression of fra-1 in NIH3T3 cells led to slightly enhanced cell growth in soft agar whereas the forced coexpression of fra-1 and c-jun augmented soft agar growth almost to the same extent as ras oncogene mediated transformation. Strongly increased anchorage independent growth of fra-1 overexpressing rat ®broblasts and tumor formation of such cells in athymic mice was shown by Bergers et al. (1995) . These observations suggest that Fra-1 contributes to neoplastic transformation. Consistent with this view is the ®nding that fra-1 is upregulated in rat renal carcinoma cells (Hino et al., 1995; Urakami et al., 1997) and tumorigenic keratinocytes (Li et al., 1998) . Whether fra-1 expression is involved in human tumor formation remains to be shown.
Fra-1 might participate in neoplastic transformation through its involvement in the induction of genes whose protein products catalyze such important reaction as loosening of cell-cell contacts or triggering of tumor neovascularization. However, sustained fra-1 expression seems to result also in the silencing of genes. We have demonstrated that the expression of a dominant negative form of c-Jun in ras transformed Protein extracts were prepared 24 h after transfection. CAT assays were performed with lysates normalized for b-galactosidase activity. The values are the average of three independent experiments and the standard deviations are given by the error bars. (b) The Ki-ras transformed cell line DT and the revertant cell line DTR1 were serum starved (0) and stimulated with 10% FCS for 30 min. RNA was collected and subjected to Northern blot analysis using a c-fos speci®c probe. The ethidium bromide stained gel is depicted below the autoradiogram ®broblasts can rescue c-fos gene expression, indicating that c-fos gene repression is an AP-1 mediated eect. Furthermore, we have shown that AP-1 consisting of Fra-1 and c-Jun represses c-fos gene expression more strongly than other forms of AP-1. While this work was in progress Mechta et al. (1997) have also provided strong evidence for c-fos gene repression by Fra-1 containing AP-1. Likewise, silencing of the c-fos gene in response to NGF and EGF has been observed in Fra-1 overproducing PC-12 cells (Ito et al., 1990) . Fra-1 overexpression was also found to be inhibitory for egr-1 gene expression (Gius et al., 1990) . egr-1 is an immediate early gene which is strongly activated in serum stimulated ®broblasts. We have also observed that egr-1 is no longer induced in ras transformed NFR-2 cells during the G 0 /G 1 transition (unpublished results). c-fos is very rapidly induced upon serum and growth factor stimulation of quiescent cells while fra-1 mRNA and protein appear later . The kinetics of the appearance of fra-1 and the disappearance of c-fos mRNA are compatible with the ®nding that Fra-1 is involved in c-fos gene suppression.
The repression of c-fos and other immediate early transcription factor has been observed in several laboratories. Yu et al., (1993) have described the lack of c-fos, c-jun, junB and egr-1 expression in serum stimulated ras and src transformed rodent cell lines. Likewise, the absence of c-fos gene expression in ras transformed cells in response to TPA, PDGF, Ca 2+ ionophore, serum, and cAMP has been described by several authors (Lin et al., 1988; Mechta et al., 1997; Nose et al., 1989; Okimoto et al., 1996; Suzuki et al., 1989; Zullo and Faller, 1988) and NGF and bFGF mediated c-fos gene induction was found to be attenuated in N-ras transformed PC-12 cells (Thomson et al., 1990) . In ras transformed Jurkat cells Ca 2+ in¯ux mediated c-fos and egr-1 gene expression is abolished . Most interestingly, c-fos, c-jun, and egr-1 are downregulated in over 70% of human non-small cell lung carcinomas (Levin et al., 1995) and c-fos is one of the most strongly downregulated genes in human colon cancer (Zhang et al., 1997) . The repression of c-fos in neoplastically transformed cells and in tumors might be a functionally insigni®cant by-product of fra-1 upregulation. But it might as well be important for tumorigenicity. Evidence for the latter has been provided: MHC class I downregulation in lung carcinoma and melanoma cells correlates with c-fos repression and the forced expression of c-fos and c-jun led to MHC class I reexpression and a signi®cant reduction in tumorigenic and metastatic properties (Yamit Hezi et al., 1994) . cfos is often involved in cell dierentiation and its absence might maintain cells in the proliferative, undierentiated state. Fra-1 mediated c-fos downregulation in PC-12 cells prevented NGF mediated dierentiation and resulted in an increased proliferation rate (Ito et al., 1990) .
Some of the known AP-1 responsive genes, which are overexpressed in tumors, encode proteins that contribute to the tumorigenic phenotype. They do so either as proteases which mediate cell motility and entry into the vasculature (stromelysin, interstitial collagenase) or as mediators of tumor neovascularization (proliferin, VEGF). T1 is a soluble IL-1 receptorlike protein of unknown function but with a very restricted expression pattern. Tumor associated T1 gene expression does not seem to be a widespread phenomenon albeit slightly elevated T1 gene expression has been observed in experimentally induced murine mammary carcinomas (Rossler et al., 1993) . This is consistent with our observation that T1 gene expression is not stimulated by those AP-1 proteins which prevail in ras transformed cells. Thus, AP-1 responsiveness of a gene does not necessarily imply that it is overexpressed in oncogenically transformed cells with elevated AP-1 activity.
ras oncogene expression results in the establishment of a new equilibrium of gene expression which includes gene activation as well as gene repression. The transition state, which precedes this new equilibrium, can be mimicked in conditional oncogene expression systems. However, using such systems one has to keep in mind that the molecular eects that result from transient and sustained oncogene expression might be of quite dierent nature. Based on studies with an inducible oncogene cell system we have initially described T1 as a ras and mos oncogene responsive gene. Here we have demonstrated that in a more physiological situation, namely under conditions of sustained ras oncogene expression as it occurs in many tumors, basal T1 gene expression is not elevated and its induction upon mitogenic stimulation is even repressed.
Materials and methods

Cell cultures
NIH3T3 and NFR-2 cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), penicillin at 100 units/ml, and streptomycin at 100 mg/ml. The cell lines carrying bestradiol inducible genes were grown in DMEM without phenol-red supplemented with 10% newborn calf serum (NCS). The b-estradiol analog diethylstilbestrol (Sigma, Buchs, Switzerland) was added to a ®nal concentration of 10 78 M. Proliferation arrest was achieved by incubating subcon¯uent cultures in DMEM containing 0.5% FCS (NIH3T3 and NFR-2 cells) or 1% NCS, for 1 or 2 days as speci®ed in the ®gure legends. The stable integration of the activated Ha-ras gene in the plasmid p cHa-ras (A) into the cell line 5/1 (the kind gift of M Schuermann) (Schuermann et al., 1993) , to which we refer in this article as NIH/cFos hER, gave rise to clones 3, 6, 7, 10, 11. Transfected cells were selected in 0.5 mg/ml G418 and 1 mg/ml hygromycin. The TAR cell line was generated by cotransfecting plasmid pGC/ras(A) containing an inducible Ha-ras (EJ) oncogene and plasmid pGal-ER-VP16 encoding a b-estradiol activable transactivator gene (Braselmann et al., 1993) into NIH3T3 cells. Plasmid pGC/ras(A) was constructed by inserting a 4.8 kb BamHI fragment of the plasmid pcHa-ras(A) (Santos et al., 1984) into the plasmid pGC (Braselmann et al., 1993) . Cell clones were selected in G418 and isolated cell lines were monitored for morphological transformation in response to b-estradiol treatment.
Plasmids
Plasmids encoding fra-1 and fra-2 were kindly provided by R Bravo. The cDNAs were cloned as EcoRI fragments into the EcoRI site of the expression plasmid pCI (Promega, Madison, WI, USA). The fosB cDNA was excised from pTZfosB (a generous gift of M Schuermann) with EcoRI and SalI and inserted into the corresponding sites of the expression plasmid pSVK3 (Pharmacia). The T1 reporter plasmid SH4.9 has been described previously . The pBLCAT2 plasmid containing the tk-minimal promoter was described elsewhere (Luckow and SchuÈ tz, 1987) .
Transfections and CAT assay
Cells were transfected using the calcium-phosphate coprecipitation method (Wigler et al., 1979) . 24 h before transfection, 10 6 cells were plated per 10-cm tissue culture dish. 6 h after the addition of the DNA precipitate, the cells were washed twice with phosphate buered saline (PBS) containing 1 mM EDTA and maintained in DMEM supplemented with 10% FCS for the indicated time periods.
NIH3T3 and NFR-2 cells were cotransfected with 10 mg reporter plasmid, 5 mg pRSV-LacZ (Bonnerot et al., 1987) and the indicated amounts of expression plasmids. Titration of the various expression plasmids (0.1 ± 10 mg) revealed that 2.5 mg DNA led to maximal stimulation of the reporter constructs. The total amount of DNA used in the transfection experiments was kept constant by the addition of pBSKS + . 24 or 48 h after transfection, cells were rinsed twice with cold PBS and scraped into 1 ml cold PBS. Cells were pelleted and resuspended in cold 40 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM NaCl. The suspension was sonicated six times at 50 W with a cell disruptor (Heat Systems-Ultrasonics, Inc.). Cell debris was removed by centrifugation. An aliquot of the supernatant was used to measure b-galactosidase activity according to Miller (1972) . Chloramphenicolacetyltransferase (CAT) assays were performed with cell extracts normalized for b-galactosidase activity and quantitated by the phase extraction method (Seed and Sheen, 1988) . The butyrylated reaction products were extracted with a mixture of tetramethylpentadecane and xylene (2 : 1) and the radioactivity was determined in a scintillation counter (Canberra Packard 1900 TR).
RNA preparation and Northern blot analysis
Total RNA was isolated according to Chomczynsky and Sacchi (1987) , denatured by glyoxylation (McMaster and Carmichael, 1977) , fractioned on 1% agarose gels (5 mg/ lane) and transferred onto nylon membranes (Genescreen plus, Du Pont). After UV cross-linking of the RNA (1200 MeJ), the membranes were hybridized at 428C with random primed, a-32 P-dCTP labeled DNA fragments Vogelstein, 1983, 1984) . The following probes were used: T1: two EcoRI-fragments (1.0 and 1.6 kb) from the plasmid pT1.11, spanning the entire T1 cDNA (available from ATCC); fos: 1 kb PstI fragment from the plasmid pfos-1, containing the cDNA of the FBJ-MuLU v-fos (Curran et al., 1982) ; fosB: 0.87 kb HindIII/HindII fragment from the plasmid pTZfosB; fra-1: 1.5 kb EcoRI fragment from the plasmid fra-1; fra-2: 2.3 kb EcoRI fragment from the plasmid fra2/ 5; c-jun: 1.5 kb HindIII/EcoRI fragment from the plasmid pTZjun (gift from M Schuermann); junB: 470 bp BamHI/ SacI fragment from the plasmid pSG-junB; junD: 1.5 kb EcoRI fragment from the plasmid pSG-junD; Ha-ras: 2.9 kb SacI fragment from the plasmid pcHa-ras(A) (Santos et al., 1984) .
Preparation of nuclear extracts
Nuclear extracts were prepared according to Schreiber et al. (1989) with minor modi®cations. NIH3T3 cells were washed twice with ice cold PBS, scraped o the plates and sedimented by centrifugation. The pellet was suspended in ice cold buer A (10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol) containing a cocktail of protease inhibitors (Hagenbuchle and Wellauer, 1992 ) and immediately centrifuged. 5 ml of buer A were added to the pellet and after an incubation period of 15 min on ice, the suspension was passed three times with a syringe through a 24-gauge needle to break the swollen cells. Nuclei were pelleted by centrifugation and suspended in an equal volume of 40 mM HEPES (pH 7.9), 800 mM NaCl, 2 mM EDTA, 2 mM EGTA, 2 mM dithiothreitol containing a cocktail of protease inhibitors (Hagenbuchle and Wellauer, 1992) . After vigorous shaking for 15 min at 48C, nuclear debris was removed by centrifugation. Protein concentrations of the nuclear extracts were determined (Bradford, 1976) . Aliquots were frozen in liquid nitrogen and stored at 7808C.
Electrophoretic mobility shift assay (EMSA)
The probe for the EMSA were produced by annealing of complementary oligonucleotides centered around the TRE of the T1 enhancer [the sequence of the T1 TRE is: 5' CTAGAATGTCTTAGTCACTTTAG 3' (upper oligonucleotide), 5' TTACAGAATCAGTGAAATCCTAG 3' (lower oligonucleotide)] and ®lling in of the recessive ends with Klenow enzyme in the presence of a-32 P-dCTP (3000 Ci/mmol, Amersham, Amersham Pharmacia Biotech, Uppsala, Sweden). Unincorporated deoxynucleoside triphosphates were removed on Sephadex G-50 Nick columns (Pharmacia, Amersham Pharmacia Biotech, Uppsala, Sweden). 20 000 c.p.m. (Cerenkow) probe (approximately 5 ± 10 fmol DNA) were incubated with 4 mg of nuclear extract in 15 ml 20 mM HEPES, pH 7.9, 60 mM NaCl, 1 mM EDTA, 0.25 mg bovine serum albumin, 1 mg poly (dI-dC) (Pharmacia) and 4% Ficoll for 15 min at room temperature.
For antibody interference experiments, antisera directed against the Fos and Jun family members (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) were added to the nuclear extracts 10 min after the addition of the radioactive probe. After an additional incubation period of 30 min samples were subjected to electrophoresis on a 5% non-denaturing polyacrylamide gel in 22 mM Tris-borate, 0.25 mM EDTA, pH 7.9, for 1.5 h at 200 V. Gels were exposed to Fuji X-Ray ®lms. To quantify results of gel retardation assays, autoradiographs were analysed by quantitative scanning densitometry.
